Search research articles
Contact Us
Filters
Showing results (61-70 of 80) with videos related to
Page
of 8
Sort By:
Gynecologic Oncology
|
October 29, 2011
The BCL2 antagonist of cell death pathway influences endometrial cancer cell sensitivity to cisplatin
Hye Sook Chon, Douglas C Marchion, Yin Xiong, et al.
Journal of Translational Medicine
|
April 11, 2006
Cytokines, GM-CSF and IFNgamma administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin
Sachin M Apte, Saroj Vadhan-Raj, Lorenzo Cohen, et al.
Oncology Reports
|
November 14, 2013
Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel
Ning Chen, Hye Sook Chon, Yin Xiong, et al.
Gynecologic Oncology
|
November 28, 2019
High-dose intensity-modulated chemoradiotherapy in vulvar squamous cell carcinoma: Outcome and toxicity
Anupam Rishi, Madeline Rollins, Kamran A Ahmed, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 20, 2026
A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancer
Robert M Wenham, Andrea L Buras, Sarah W Gordon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 29, 2012
Characterizing the efficacy of fermented wheat germ extract against ovarian cancer and defining the genomic basis of its activity
Patricia L Judson, Entidhar Al Sawah, Douglas C Marchion, et al.
Oncology Reports
|
March 8, 2013
A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth
Douglas C Marchion, Elona Bicaku, Yin Xiong, et al.
British Journal of Cancer
|
May 19, 2012
In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival
E Bicaku, Y Xiong, D C Marchion, et al.
International Journal of Oncology
|
May 4, 2012
The O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian cancer
Nadim Bou Zgheib, Yin Xiong, Douglas C Marchion, et al.
International Journal of Molecular Medicine
|
February 6, 2015
BAD-mediated apoptotic pathway is associated with human cancer development
Xiaomang B Stickles, Douglas C Marchion, Elona Bicaku, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 80) with videos related to
Sort By:
Page
of 8
Gynecologic Oncology
|
October 29, 2011
The BCL2 antagonist of cell death pathway influences endometrial cancer cell sensitivity to cisplatin
Hye Sook Chon, Douglas C Marchion, Yin Xiong, et al.
Journal of Translational Medicine
|
April 11, 2006
Cytokines, GM-CSF and IFNgamma administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin
Sachin M Apte, Saroj Vadhan-Raj, Lorenzo Cohen, et al.
Oncology Reports
|
November 14, 2013
Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel
Ning Chen, Hye Sook Chon, Yin Xiong, et al.
Gynecologic Oncology
|
November 28, 2019
High-dose intensity-modulated chemoradiotherapy in vulvar squamous cell carcinoma: Outcome and toxicity
Anupam Rishi, Madeline Rollins, Kamran A Ahmed, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 20, 2026
A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancer
Robert M Wenham, Andrea L Buras, Sarah W Gordon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 29, 2012
Characterizing the efficacy of fermented wheat germ extract against ovarian cancer and defining the genomic basis of its activity
Patricia L Judson, Entidhar Al Sawah, Douglas C Marchion, et al.
Oncology Reports
|
March 8, 2013
A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth
Douglas C Marchion, Elona Bicaku, Yin Xiong, et al.
British Journal of Cancer
|
May 19, 2012
In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival
E Bicaku, Y Xiong, D C Marchion, et al.
International Journal of Oncology
|
May 4, 2012
The O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian cancer
Nadim Bou Zgheib, Yin Xiong, Douglas C Marchion, et al.
International Journal of Molecular Medicine
|
February 6, 2015
BAD-mediated apoptotic pathway is associated with human cancer development
Xiaomang B Stickles, Douglas C Marchion, Elona Bicaku, et al.
Page
of 8